In addition to applying recent discoveries to design better analgesics that activate MOR and MDD treatments that block KOR, one exciting possibility is to boost the activity of endogenous opioid peptides with a positive allosteric modulator of MOR. The gene discussed is OPRK1; the disease is major depressive disorder.